Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine

Bibliographic Details
Main Authors:	Ita Fitzgerald, Sarah O'Dwyer, Margaret Brooks, Laura Sahm, Erin Crowley, Ciara Ní Dhubhlaing
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Psychiatry
Subjects:	metformin antipsychotic-induced weight gain schizophrenia metabolic side effect olanzapine
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2021.730769/full

Similar Items

Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?
by: Ita Fitzgerald, et al.
Published: (2024-11-01)

Informing the development of antipsychotic-induced weight gain management guidance: patient experiences and preferences – qualitative descriptive study
by: Ita Fitzgerald, et al.
Published: (2024-09-01)

Effect of metformin on olanzapine-induced weight gain: A 12-week randomised open-label study
by: G. Chetan Kumar, et al.
Published: (2025-01-01)

Predicting antipsychotic-induced weight gain in first episode psychosis – A field-wide systematic review and meta-analysis of non-genetic prognostic factors
by: Ita Fitzgerald, et al.
Published: (2023-01-01)

Olanzapine-induced skin eruptions
by: Nishtha Chawla, et al.
Published: (2017-01-01)

Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)

Olanzapine-induced Pancytopenia: Case Report
by: A Prajnashree, et al.
Published: (2024-11-01)

Is there association of olanzapine and pulmonary embolism: A case report
by: Lumin Wang, et al.
Published: (2022-06-01)

Case of Secondary Tics Associated With Olanzapine in an Adult
by: Eric W. Mills, et al.
Published: (2017-08-01)

Acute Generalized Exanthematous Pustulosis Induced by Olanzapine
by: Susanne Christen, et al.
Published: (2006-01-01)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-06-01)

Olanzapine-induced bilateral pedal and pretibial edema: A case report
by: Behice Han Almis, et al.
Published: (2019-06-01)

Olanzapine-associated hypothermia: a case report of a rare event
by: Manuel Monti, et al.
Published: (2018-02-01)

Early Lipid Metabolic Effects of the Anti-Psychotic Drug Olanzapine on Weight Gain and the Associated Gene Expression
by: Chen CC, et al.
Published: (2022-03-01)

Metformin ameliorates olanzapine-induced obesity and glucose intolerance by regulating hypothalamic inflammation and microglial activation in female mice
by: Sang Bum Suh, et al.
Published: (2022-10-01)

Olanzapine as a Cause of Urinary Incontinence: A Case Report
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)

Assessment of lipid response to acute olanzapine administration in healthy adults
by: Avital Nahmias, et al.
Published: (2020-04-01)

Olanzapine as a cause of urinary incontinence: a case report.
by: Mobolaji Usman Dada, et al.
Published: (2012-09-01)

Olanzapine-induced skin rash: A case report
by: Mansi Shah, et al.
Published: (2019-01-01)

Quetiapine and olanzapine misuse prevalence in a US general population sample
by: Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, et al.
Published: (2023-04-01)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
by: Maria-Ioanna Stefanou, et al.
Published: (2020-04-01)

Pancreatitis following Olanzapine Therapy: A Report of Three Cases
by: Thomas A. Kerr, et al.
Published: (2007-06-01)

A Review of Vesicular and Polymeric Nano-systems in Olanzapine Drug Delivery
by: Javad Setareh, et al.
Published: (2022-01-01)

Comparative evaluation of pancreatic histopathology of rats treated with olanzapine, risperidone and streptozocin
by: Rehmat Shah, et al.
Published: (2018-11-01)

The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature
by: G. Saudemont, et al.
Published: (2020-04-01)

Teratogenicity with olanzapine
by: Sathya Prakash, et al.
Published: (2014-01-01)

Effect on Body Weight and Adipose Tissue by Cariprazine: A Head-to-Head Comparison Study to Olanzapine and Aripiprazole in Rats
by: László-István Bába, et al.
Published: (2020-10-01)

Olanzapine: Association Between a Typical Antipsychotic Drug and Aortic Calcification
by: Chao Zhang, et al.
Published: (2021-09-01)

Olanzapine-Induced Diabetic Ketoacidosis: A Reversible Etiology Overlooked in Psychiatric Patients
by: Avish K. Jain, DO, et al.
Published: (2024-01-01)

Olanzapine-Induced Hyperprolactinemia: Two Case Reports
by: Pedro Cabral Barata, et al.
Published: (2019-07-01)

Hematological safety of olanzapine
by: Asem A Alageel, et al.
Published: (2016-09-01)

Olanzapine in the treatment of anorexia nervosa: a systematic review
by: Sidar Çöpür, et al.
Published: (2020-06-01)

One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
by: Mohammed Zain Ulabedin Adhoni, et al.
Published: (2021-10-01)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
by: Hong Jihyung, et al.
Published: (2012-12-01)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
by: Huimei An, et al.
Published: (2022-06-01)

The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
by: Ranran Li, et al.
Published: (2018-04-01)

An unusual complication of a long-acting injectable antipsychotic: deep venous thrombosis caused by olanzapine pamoate
by: Serhat Tunç, et al.
Published: (2018-04-01)

Amisulpride and olanzapine in Capgras Syndrome
by: G Sanghamitra, et al.
Published: (2017-01-01)

Whole-brain Transcriptomic Analysis of Weight Gain Mice induced by Olanzapine
by: ZHANG Yuan, et al.
Published: (2023-06-01)

A retrospective review of intramuscular olanzapine and parenteral benzodiazepine coadministration in the emergency department
by: Jessica Laub, PharmD, BCEMP, et al.
Published: (2024-08-01)